IN Brief:
- DELO has introduced five new medical-electronics adhesives with IBOA- and TPO-free formulations.
- The range covers wearable housing bonds, sensor potting, sealing, and process-control visibility.
- The launch reflects the growing overlap between consumer-electronics assembly methods and medical-device packaging.
DELO has expanded its medical-electronics portfolio with five new IBOA- and TPO-free adhesives, giving device manufacturers a broader set of materials for wearable housings, biosensors, potting, and sealing tasks. The range is aimed squarely at applications where biocompatibility, compact assembly, and production throughput have to be balanced without compromising reliability.
The lead product in the new group is DELO PHOTOBOND MG4202, a solvent-free adhesive developed for structural bonds including wearable-device housing assembly. DELO said the material cures in one second at 1000 mW/cm² LED intensity at 400nm with a 100µm layer thickness, and operates across a temperature range of -40°C to +125°C. Alongside it, DELO PHOTOBOND MG4191 is positioned as a lower-viscosity multi-purpose material with water resistance and flow-resistant properties for a broader spread of medical-device assemblies.
The other three additions fill more specialised roles. DELO PHOTOBOND MG4094 adds fluorescence for visual process control, MG4186 is tuned for peel resistance and long-term reliability, and MG4164 combines blue fluorescence with sealing capability for formed-in-place and cured-in-place gasket applications. The new range also sits alongside DELO’s existing MG4047 adhesive for potting glucose-monitoring sensors and other wearable electronics, where moisture protection and skin-contact considerations are already driving material choices.
All five new products have been tested for cytotoxicity under DIN EN ISO 10993-5 and comply with RoHS Directive 2015/863/EU. That regulatory detail is important because the materials story in medical electronics is no longer confined to strength, cure speed, or process convenience. The closer medical devices move to continuous skin contact, extended wear, and higher production volumes, the more the adhesive itself becomes part of the engineering problem. Wearables, patches, miniaturised diagnostic modules, and disposable sensor platforms all place tighter limits on outgassing, sensitising substances, and long-term stability under sweat, motion, and repeated handling.
The launch also underlines how quickly medical-electronics manufacturing is borrowing methods from semiconductor packaging and consumer-device assembly. Fast LED curing, fluorescence-assisted inspection, and lower-viscosity chemistries are already familiar ideas in high-throughput electronics production. What changes in medical devices is the compliance burden and the operating environment. Materials now need to support miniaturisation and production yield while also surviving moisture exposure, sterilisation considerations, mechanical flex, and more demanding documentation requirements.
That shift is likely to keep pulling adhesive suppliers further into the product-design conversation. In compact medical electronics, the adhesive is no longer just a joining medium added late in the process. It can influence enclosure thickness, cure-station design, inspection strategy, moisture protection, and even whether a sensor package is practical at scale. DELO’s expansion is therefore less about a single new chemistry than about giving engineers a fuller materials toolkit as medical devices continue to move toward smaller, more integrated, and more wearable formats.
